Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 4
1953 1
1954 1
1955 2
1957 3
1959 1
1963 1
1965 1
1971 1
1976 1
1977 1
1979 5
1980 4
1981 4
1982 1
1983 5
1984 4
1985 8
1986 3
1987 2
1988 7
1989 6
1990 10
1991 8
1992 5
1993 5
1994 5
1995 11
1996 11
1997 8
1998 8
1999 8
2000 15
2001 8
2002 22
2003 33
2004 37
2005 36
2006 57
2007 47
2008 50
2009 57
2010 62
2011 62
2012 72
2013 115
2014 121
2015 122
2016 120
2017 138
2018 144
2019 163
2020 244
2021 266
2022 301
2023 272
2024 281
2025 346
2026 152

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,101 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of Rituximab Therapy to Sustain Remission in Young Children With Childhood Nephrotic Syndrome.
Chan EY, Au CT, Yu EL, Angeletti A, Arslan Z, Boyer O, Chan CY, Colucci M, Dorval G, Dossier C, Ghiggeri GM, Hamada R, Hogan J, Ishikura K, Kamei K, Kemper MJ, Ma AL, Parekh RS, Radhakrishnan S, Robinson C, Shen Q, Sinha R, Subun C, Teo S, Vivarelli M, Webb H, Xu H, Yamamura T, Yap HK, Tullus K. Chan EY, et al. Among authors: ma al. Kidney Int Rep. 2026 Apr 6;11(6):106526. doi: 10.1016/j.ekir.2026.106526. eCollection 2026 Jun. Kidney Int Rep. 2026. PMID: 42094860 Free PMC article.
Safety and efficacy of allogeneic CD19-directed CAR-T therapy CTX110 in relapsed/refractory B-cell non-Hodgkin lymphoma.
McGuirk JP, Ghobadi A, Bachier CR, Shaughnessy PJ, Awan FT, Maakaron JE, Bishop MR, Ho PJ, Tam CS, Dickinson MJ, Darrah JM, Waller EK, Murthy HS, Ross A, Williams LM, Pan C, Stevens WN, Serwer L, Nguyen T, Terrett J, Kalaitzidis D, Ma A, Xu H, Benton MD, Weaver A, Cohen SB, Maziarz RT, Cheah CY. McGuirk JP, et al. Among authors: ma a. Blood Adv. 2026 May 5:bloodadvances.2026020123. doi: 10.1182/bloodadvances.2026020123. Online ahead of print. Blood Adv. 2026. PMID: 42085626
Prevalence of antibody drug conjugated-induced nausea and vomiting (ADCINV) in patients with cancer.
Chow R, Zhang D, Kannout S, Ma A, Zheng C, Blayne A, Dou A, Talwar S, Fazelzad R, Rugo HS, Ruhlmann CH, Iihara H, Affronti ML, Leigh J, Scotté F, Eng L; MASCC Antiemetic Study Group and the MASCC Emerging Toxicities Study Group. Chow R, et al. Among authors: ma a. Support Care Cancer. 2026 May 2;34(5):486. doi: 10.1007/s00520-026-10674-2. Support Care Cancer. 2026. PMID: 42068413 Free PMC article.
3,101 results